Future Science GroupBrowse
Supplementary Figure 2.jpg (757.29 kB)
Download file

Supplementary Figure 2. Treatment patterns in patients with metastatic non-small-cell lung cancer in the era of immunotherapy

Download (757.29 kB)
figure
posted on 2021-04-14, 10:19 authored by David Stenehjem, Solomon Lubinga, Keith A Betts, Wenxi Tang, Mads Jenkins, Yongqin YuanYongqin Yuan, John Hartman, Sumati Rao, Jenny LamJenny Lam, David WaterhouseDavid Waterhouse

Sankey diagram of treatment patterns for patients initiating 1L therapy between August to December 2018 (A), January to June 2019 (B) and July to December 2019 (C). 1L: first-line; 2L: second-line; 3L: third-line; Nivo: nivolumab; Pembro: pembrolizumab.

History

Usage metrics

Read the peer-reviewed publication

Treatment patterns in patients with metastatic non-small-cell lung cancer in the era of immunotherapy
Future OncologyFuture Oncology

Categories

Keywords

Non-small cell lung cancerreal-world outcomesimmunotherapyimmune checkpoint inhibitorsCancer Therapy (excl. Chemotherapy and Radiation Therapy)Solid Tumours

Licence

CC BY-NC-ND 4.0

Exports